Our corporate DNA is research and analysis. The entry-point to all our projects is evidence-based research and analysis, ensuring the latest and best understanding of the market and where our unbiased primary research takes us to the next step: understanding the future.
Our research is the result of an extensive network of partners, across all tiers of the pharmaceutical and biotech industries globally. Combined with our knowledge and evidence-based analysis of: regulatory, clinical, patent, and industry value chains, this constitutes the core competences of Jakob and Partners.